23 Polen Capital Novo Nordisk Trades
Polen Capital acquired 7.77 Million Novo Nordisk shares worth $998 Million. That's 2.36% of their equity portfolio (17th largest holding). The first Novo Nordisk trade was made in Q2 2013. Since then Polen Capital bought shares eighteen more times and sold shares on four occasions. The investor's estimated purchase price is $1.27 Billion, resulting in a loss of 22%.
News about Novo Nordisk - ADR and Polen Capital
KKR, Novo Nordisk, others bid for Healthium buy
Global PE major KKR and pharma major Novo Nordisk have submitted final bids for Healthium. A third, joint bid has come from India-focused PE firm ChrysCapita...
BMO Capital starts Novo Nordisk at Outperform
https://www.investing.com/news/stock-market-news/bmo-capital-starts-novo-nordisk-at-outperform-432SI-3376910
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
WHY: NEW YORK, NY - ( NewMediaWire ) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities clai...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
WHY: NEW YORK, NY - ( NewMediaWire ) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities clai...